BAX and central nervous system cancer: The pentapeptide increases caspase 3, 8, and 9 activities and Bax, Fas, and FasL expression, decreases Bcl-2 expression, augments cytoplasmic Ca++ influx, and increases NFAT1 levels in the nucleus of C6 glioma cells [83].